Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd.
Plaintiff: Novartis Pharmaceuticals Corporation
Defendant: Crystal Pharmaceutical (Suzhou) Co., Ltd.
Case Number: 1:2021cv01347
Filed: September 24, 2021
Court: US District Court for the District of Delaware
Presiding Judge: Leonard P Stark
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on November 14, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 17, 2021 Opinion or Order Filing 11 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Certifications for Nicholas N. Kallas, Christina Schwarz, Christopher E. Loh, and Jared L. Stringham)(Silver, Daniel)
October 29, 2021 Opinion or Order Filing 10 ANSWER to #7 Answer to Complaint, Counterclaim by Novartis Pharmaceuticals Corporation.(Silver, Daniel)
October 14, 2021 Opinion or Order SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove, and Elizabeth M. Crompton, of the law firm of Parker Poe Adams & Bernstein, LLP filed by Crystal Pharmaceutical (Suzhou) Co., Ltd. Signed by Judge Leonard P. Stark on 10/14/21. (ntl)
October 14, 2021 Opinion or Order Pro Hac Vice Attorney C. Kyle Musgrove for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
October 14, 2021 Opinion or Order Pro Hac Vice Attorney Scott A. Cunning, II for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
October 14, 2021 Opinion or Order Pro Hac Vice Attorney Elizabeth M. Crompton for Crystal Pharmaceutical (Suzhou) Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
October 12, 2021 Opinion or Order Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Scott A. Cunning II, C. Kyle Musgrove, and Elizabeth M. Crompton, of the law firm of Parker Poe Adams & Bernstein, LLP - filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick)
October 8, 2021 Opinion or Order Filing 8 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Crystal Pharmatech Co., Ltd. for Crystal Pharmaceutical (Suzhou) Co., Ltd. filed by Crystal Pharmaceutical (Suzhou) Co., Ltd.. (Gattuso, Dominick)
October 8, 2021 Opinion or Order Filing 7 ANSWER to #1 Complaint, , COUNTERCLAIM against Novartis Pharmaceuticals Corporation by Crystal Pharmaceutical (Suzhou) Co., Ltd..(Gattuso, Dominick)
September 29, 2021 Opinion or Order Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb)
September 24, 2021 Opinion or Order Filing 6 Summons Issued with Magistrate Consent Notice attached as to Crystal Pharmaceutical (Suzhou) Co., Ltd. on 9/24/2021. (apk)
September 24, 2021 Opinion or Order Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (apk)
September 24, 2021 Opinion or Order Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,517,226 ;9,937,143. (apk)
September 24, 2021 Opinion or Order Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/13/2021. Date of Expiration of Patent: 08/22/2033.Thirty Month Stay Deadline: 07/7/2023. (apk)
September 24, 2021 Opinion or Order Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk)
September 24, 2021 Opinion or Order Filing 1 COMPLAINT filed against Crystal Pharmaceutical (Suzhou) Co., Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3707044.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(apk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Crystal Pharmaceutical (Suzhou) Co., Ltd.
Represented By: C. Kyle Musgrove
Represented By: Elizabeth M. Crompton
Represented By: Scott A. Cunning, II
Represented By: Dominick T. Gattuso
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?